RÉSUMÉ
Conventional angiography is insufficient for evaluating the therapeutic effect of cardiac regeneration therapy. A microangiographic X-ray system using a cerium anode was developed. Cerium has a characteristic X-ray with a peak at 34.6 keV, which allows visualization of tiny amounts of iodine. The performance of the cerium anode X-ray system was evaluated in two excised normal canine hearts and in excised ischemic canine hearts treated with c-kit-positive cardiac stem cells (5 canines) or without cells (5 control canines). In the normal canines, branches penetrating from the left anterior descending artery into the myocardium were visualized, down to third-order branches. In just the treated hearts treated with stem cells, small vessels characterized by irregular vessel walls were observed. The cerium anode X-ray system allowed visualization of microvessels in excised ischemic canine hearts, and may evaluate the effect of cardiac stem cell therapy.
Sujet(s)
Vaisseaux coronaires/imagerie diagnostique , Coeur/imagerie diagnostique , Infarctus du myocarde/imagerie diagnostique , Transplantation de cellules souches/méthodes , Animaux , Cérium , Modèles animaux de maladie humaine , Chiens , Infarctus du myocarde/thérapie , Rayons XRÉSUMÉ
PURPOSE: Although nitroxyl radicals such as 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO) scavenge free radicals, their short half-life and considerable side effects such as systemic hypotension and bradycardia have limited their clinical application. Since a radical-containing nanoparticle (RNP) delivers nitroxyl radicals with a prolonged half-life specific to ischemic hearts, we investigated whether RNPs reduce infarct size without the occurrence of substantial side effects and whether nitric oxide (NO) contributes to the cardioprotective effects of RNPs. METHODS: The left anterior descending coronary arteries of dogs were occluded for 90 min, followed by reperfusion for 6 h. Either RNPs, micelles (not containing TEMPO) (control), or 4-hydroxy-TEMPO (TEMPOL) was injected into a systemic vein for 5 min before reperfusion. We evaluated the infarct size, myocardial apoptosis, plasma NO levels in coronary venous blood, and the RNP spectra using an electron paramagnetic resonance assay. RESULTS: RNPs reduced infarct size compared with the control group and TEMPOL group (19.5 ± 3.3 vs. 42.2 ± 3.7 vs. 30.2 ± 3.4%). RNPs also reduced myocardial apoptosis compared with the control and TEMPOL group. Coronary venous NO levels increased in the RNP group. CONCLUSIONS: In conclusion, the administration of 2,2,6,6-tetramethylpiperidine-1-oxyl as a RNP exerted cardioprotective effects against ischemia and reperfusion injury in canine hearts without exerting unfavorable hemodynamic effects. RNPs may represent a promising new therapy for patients with acute myocardial infarction.
Sujet(s)
Cardiotoniques/usage thérapeutique , N-oxydes cycliques/usage thérapeutique , Vecteurs de médicaments/composition chimique , Infarctus du myocarde/prévention et contrôle , Lésion de reperfusion myocardique/traitement médicamenteux , Nanoparticules/composition chimique , Animaux , Cardiotoniques/administration et posologie , Circulation coronarienne/effets des médicaments et des substances chimiques , N-oxydes cycliques/administration et posologie , Modèles animaux de maladie humaine , Chiens , Injections veineuses , Infarctus du myocarde/étiologie , Infarctus du myocarde/anatomopathologie , Lésion de reperfusion myocardique/complications , Lésion de reperfusion myocardique/anatomopathologie , Monoxyde d'azote/sang , Marqueurs de spinRÉSUMÉ
OBJECTIVE: Lacunar stroke may be caused by infarction of small perforating branches of the middle cerebral artery. We developed a microangiographic X-ray system using a cerium anode to evaluate the perforating branches. METHODS: Iodine has K-edges at 33.2 kilo electron volts. Cerium yields a characteristic X-ray of 34.6 kilo electron volts, therefore, the cerium anode X-ray system could detect tiny amounts of contrast material. First, an X-ray chart was used to evaluate the resolution. Second, the brains of mice were dissected and irradiated. Third, the brains of dogs were excluded and irradiated. Fourth, iodine was perfused into the carotid artery of living dogs during brain imaging. RESULTS: In the first experiment, the cerium anode X-ray system elicited 4.86 clear line pairs. In mice, the perforating branches of the middle cerebral artery could be visualized. The perforating branches were clearly observed in dog brains ex situ even through an acrylic plate, but not in conventional X-ray images. Iodine moving inside the perforating branches was visualized in dog brains in situ using the cerium anode X-ray system. CONCLUSION: The cerium anode X-ray system allowed us to visualize the perforating branches of the middle cerebral artery in living dogs.
Sujet(s)
Encéphale/vascularisation , Angiographie cérébrale/instrumentation , Microvaisseaux/imagerie diagnostique , Animaux , Angiographie cérébrale/méthodes , Cérium , Produits de contraste , Chiens , Électrodes , Mâle , Souris SCID , Modèles animauxRÉSUMÉ
AIM: As altered blood flow in the cerebral perforating arteries (PA) might be related to development of cerebral white matter hyperintensities, we examined whether the hemodynamic relationship of the PA and middle cerebral artery (MCA) is altered in rat models of diabetes, compared with normal rats and a rat model of sinoatrial denervation (blood pressure fluctuation model). METHODS: We used microangiography with monochromatic synchrotron radiation to measure the diameters of the PA and MCA at 4.5 µm resolution in five groups of rats: (i) Long-Evans Tokushima Otsuka (LETO); (ii) Otsuka Long-Evans Tokushima Fatty (a model of type 2 diabetes with obesity); (iii) LETO with sinoaortic denervation (LETO + SAD); (iv) F344; and (v) F344 + streptozotocin (a model of type 1 diabetes). RESULTS: Compared with LETO, Otsuka Long-Evans Tokushima Fatty rats showed a significant reduction in the diameter of both PA and MCA, though the PA/MCA diameter ratio was unchanged. In contrast, compared with LETO, LETO + SAD rats showed an increased MCA diameter, and the PA/MCA diameter ratio was decreased. Compared with F344 rats, the MCA diameter was increased in F344 + streptozotocin rats, and the PA/MCA diameter ratio was decreased. Scatter diagrams showed that the diameters of the PA and MCA were essentially independent of each other in the two types of diabetic models. CONCLUSION: PA were consistently visualized at high resolution by means of microangiography using synchrotron radiation. The present results show that rat diabetic models exhibit changes in PA diameter and PA/MCA diameter ratio, which might be related to the development of diabetes-associated cerebral white matter hyperintensities.
Sujet(s)
Glycémie/analyse , Circulation cérébrovasculaire/physiologie , Diabète expérimental/complications , Substance blanche/vascularisation , Microtomographie aux rayons X/méthodes , Animaux , Artères cérébrales/imagerie diagnostique , Modèles animaux de maladie humaine , Mâle , Répartition aléatoire , Rats , Rats de lignée F344 , Rats de lignée OLETF , Rat Long-Evans , Sensibilité et spécificité , Statistique non paramétrique , Synchrotrons , Substance blanche/anatomopathologieRÉSUMÉ
OBJECTIVES: The spatial resolution of conventional angiographic systems is not enough to predict diabetic microangiopathy in arterioles (20-200 µm). METHODS: To determine whether fingertip synchrotron (SR) radiation microangiography has enough spatial resolution to quantitate arteriolar diameter changes, and whether an arteriolar paradoxical vasoconstriction is a characteristic observation for diabetic microangiopathy, diameter reduction as arteriolar branching and difference of the diameter changes induced by acetylcholine between control (n = 5) and diabetic rats (n = 5) were analyzed. RESULTS: Fingertip SR microangiography visualized the arterioles with a diameter range of 30-300 µm and demonstrated vascular diameter reduction as branching with a fixed ratio (r = 0.93, P < 0.004 and r = 0.73, P < 0.001). A vasodilatory reaction was induced by acetylcholine in the control (142.4 ± 61.9 to 190.9 ± 73.5, P < 0.05, n = 25), in contrast, paradoxical vasoconstriction in diabetic rats (201.6 ± 83.0 to 16 0.4 ± 67.9, P < 0.05, n = 37). Histological angiopathy was noted only in the diabetic rats. CONCLUSION: In conclusion, the fingertip SR microangiography is useful to predict diabetic micrangiopahty.
Sujet(s)
Angiographie/méthodes , Artérioles/imagerie diagnostique , Angiopathies diabétiques/imagerie diagnostique , Membre thoracique/vascularisation , Synchrotrons , Orteils/vascularisation , Acétylcholine/pharmacologie , Animaux , Artérioles/anatomopathologie , Diabète de type 1/complications , Diabète de type 1/anatomopathologie , Diabète de type 2/complications , Diabète de type 2/anatomopathologie , Angiopathies diabétiques/étiologie , Angiopathies diabétiques/anatomopathologie , Modèles animaux de maladie humaine , Diagnostic précoce , Mâle , Valeur prédictive des tests , Rats de lignée F344 , Rats de lignée OLETF , Vasoconstriction/effets des médicaments et des substances chimiques , Vasodilatation/effets des médicaments et des substances chimiquesRÉSUMÉ
The fundamental performance of microangiography has been evaluated using the S-band linac-based inverse-Compton scattering X-ray (iCSX) method to determine how many photons would be required to apply iCSX to human microangiography. ICSX is characterized by its quasi-monochromatic nature and small focus size which are fundamental requirements for microangiography. However, the current iCSX source does not have sufficient flux for microangiography in clinical settings. It was determined whether S-band compact linac-based iCSX can visualize small vessels of excised animal organs, and the amount of X-ray photons required for real time microangiography in clinical settings was estimated. The iCSX coupled with a high-gain avalanche rushing amorphous photoconductor camera could visualize a resolution chart with only a single iCSX pulse of â¼3â ps duration; the resolution was estimated to be â¼500â µm. The iCSX coupled with an X-ray cooled charge-coupled device image sensor camera visualized seventh-order vascular branches (80â µm in diameter) of a rabbit ear by accumulating the images for 5 and 30â min, corresponding to irradiation of 3000 and 18000 iCSX pulses, respectively. The S-band linac-based iCSX visualized microvessels by accumulating the images. An iCSX source with a photon number of 3.6 × 10(3)-5.4 × 10(4) times greater than that used in this study may enable visualizing microvessels of human fingertips even in clinical settings.
Sujet(s)
Angiographie/instrumentation , Oreille/imagerie diagnostique , Coeur/imagerie diagnostique , Microvaisseaux/imagerie diagnostique , Diffusion de rayonnements , Angiographie/méthodes , Animaux , Chiens , Oreille/vascularisation , Humains , Microcirculation/physiologie , Modèles animaux , LapinsRÉSUMÉ
Carperitide is effective for heart failure (HF) owing to its diuretic and vasodilatory effects. This recombinant peptide may also have direct cardioprotective effects because carperitide reduces the severity of heart failure and limits infarct size. Because coronary vasodilation is an important cardioprotective treatment modality, we investigated whether carperitide increased coronary blood flow (CBF) and improved myocardial metabolic and contractile dysfunction during ischemia in canine hearts. We also tested whether carperitide is directly responsible for limiting the infarct size. We infused carperitide at 0.025-0.2 µg kg(-1) min(-1) into the canine coronary artery. A minimum dose of 0.1 µg kg(-1) min(-1) was required to obtain maximal vasodilation. To test the effects of carperitide on ischemic hearts, we reduced perfusion pressure in the left anterior descending coronary artery such that CBF decreased to one-third of the baseline value. At 10 min after carperitide was infused at a dose of 0.1 µg kg(-1) min(-1), we observed increases in CBF, fractional shortening (FS) and pH levels in coronary venous blood without concomitant increases in cardiac nitric oxide (NO) levels; these changes were attenuated using either the atrial natriuretic peptide receptor antagonist HS-142-1 or the NO synthase inhibitor L(ω)-nitroarginine methyl ester (L-NAME). Cyclic guanosine monophosphate (GMP) levels in the coronary artery were elevated in response to carperitide that also limited the infarct size after 90 min of ischemia and subsequent reperfusion. Again, these effects were blunted by L-NAME. Carperitide increases CBF, reduces myocardial contractile and metabolic dysfunction and limits infarct size. In addition, NO is necessary for carperitide-induced vasodilation and cardioprotection in ischemic hearts.
Sujet(s)
Facteur atrial natriurétique/usage thérapeutique , Vaisseaux coronaires/effets des médicaments et des substances chimiques , Infarctus du myocarde/traitement médicamenteux , Ischémie myocardique/traitement médicamenteux , Monoxyde d'azote/métabolisme , Vasodilatation/effets des médicaments et des substances chimiques , Vasodilatateurs/usage thérapeutique , Animaux , Circulation coronarienne/effets des médicaments et des substances chimiques , AMP cyclique/métabolisme , Chiens , Femelle , Contraction myocardique/effets des médicaments et des substances chimiques , Infarctus du myocarde/anatomopathologie , Ischémie myocardique/anatomopathologie , Lésion de reperfusion myocardique/traitement médicamenteux , Lésion de reperfusion myocardique/anatomopathologie , Myocarde/métabolisme , Récepteur facteur natriurétique auriculaire/effets des médicaments et des substances chimiquesRÉSUMÉ
PURPOSE: Inhalation of hydrogen (H(2)) gas has been shown to limit infarct size following ischemia-reperfusion injury in rat hearts. However, H(2) gas-induced cardioprotection has not been tested in large animals and the precise cellular mechanism of protection has not been elucidated. We investigated whether opening of mitochondrial ATP-sensitive K+ channels (mK(ATP)) and subsequent inhibition of mitochondrial permeability transition pores (mPTP) mediates the infarct size-limiting effect of H(2) gas in canine hearts. METHODS: The left anterior descending coronary artery of beagle dogs was occluded for 90 min followed by reperfusion for 6 h. Either 1.3% H(2) or control gas was inhaled from 10 min prior to start of reperfusion until 1 h of reperfusion, in the presence or absence of either 5-hydroxydecanoate (5-HD; a selective mK(ATP) blocker), or atractyloside (Atr; a mPTP opener). RESULTS: Systemic hemodynamic parameters did not differ among the groups. Nevertheless, H(2) gas inhalation reduced infarct size normalized by risk area (20.6±2.8% vs. control gas 44.0±2.0%; p<0.001), and administration of either 5-HD or Atr abolished the infarct size-limiting effect of H(2) gas (42.0±2.2% with 5-HD and 45.1±2.7% with Atr; both p<0.001 vs. H(2) group). Neither Atr nor 5-HD affected infarct size per se. Among all groups, NAD content and the number of apoptotic and 8-OHdG positive cells was not significantly different, indicating that the cardioprotection afforded by H(2) was not due to anti-oxidative actions or effects on the NADH dehydrogenase pathway. CONCLUSIONS: Inhalation of H(2) gas reduces infarct size in canine hearts via opening of mitochondrial K(ATP) channels followed by inhibition of mPTP. H(2) gas may provide an effective adjunct strategy in patients with acute myocardial infarction receiving reperfusion therapy.
Sujet(s)
Cardiotoniques/usage thérapeutique , Hydrogène/usage thérapeutique , Canaux KATP/physiologie , Protéines de transport de la membrane mitochondriale/physiologie , Infarctus du myocarde/traitement médicamenteux , Lésion de reperfusion myocardique/traitement médicamenteux , Animaux , Apoptose/effets des médicaments et des substances chimiques , Acides capriques/pharmacologie , Chiens , Hydroxyacides/pharmacologie , Méthode TUNEL , Canaux KATP/antagonistes et inhibiteurs , Protéines de transport de la membrane mitochondriale/antagonistes et inhibiteurs , Pore de transition de perméabilité mitochondriale , Infarctus du myocarde/anatomopathologie , Infarctus du myocarde/physiopathologie , Lésion de reperfusion myocardique/anatomopathologie , Lésion de reperfusion myocardique/physiopathologie , Inhibiteurs des canaux potassiques/pharmacologieRÉSUMÉ
BACKGROUND: In acute myocardial infarction, residual collateral-derived myocardial blood flow (CBF) within the ischemic area is one of the major determinants of infarct size. Management of systemic blood pressure (sBP) related to maintain collateral circulation is still difficult. The aim of this study was to reveal the influence of sBP on the rescue of area at risk by collateral circulation. METHODS: Real-time myocardial contrast echocardiography just after the onset of complete occlusion of the left circumflex coronary artery was performed in collateral-rich open-chest dogs. The video intensity of the ischemic area was evaluated during the occlusion and the CBF (A x beta) was calculated from a replenishment curve: y = A (1 - e(-beta t)). To analyze the effect of sBP on the collateral circulation, sBP was altered by infusion of nitroglycerin or etilefrine hydrochloride. To evaluate the defect size (%DS), every end-systolic myocardial contrast echocardiography image after left circumflex coronary artery occlusion was converted into binary images using custom offline software. RESULTS: The %DS increased and CBF slightly decreased at low sBP. The %DS decreased and CBF increased at high sBP. At excessively high sBP, %DS increased and CBF decreased again. CONCLUSION: Real-time myocardial contrast echocardiography, which is a useful noninvasive method to evaluate the collateral perfusion quantitatively, has a crucial role in the decision of patient treatment and management strategy of acute myocardial infarction.
Sujet(s)
Pression sanguine , Circulation collatérale , Circulation coronarienne , Échocardiographie , Étiléfrine/pharmacologie , Ventricules cardiaques/imagerie diagnostique , Nitroglycérine/pharmacologie , Vasodilatateurs/pharmacologie , Animaux , Pression sanguine/effets des médicaments et des substances chimiques , Circulation collatérale/effets des médicaments et des substances chimiques , Circulation coronarienne/effets des médicaments et des substances chimiques , Chiens , Échocardiographie/instrumentation , Échocardiographie/méthodes , Rythme cardiaque/effets des médicaments et des substances chimiques , Ventricules cardiaques/effets des médicaments et des substances chimiques , Hémodynamique/effets des médicaments et des substances chimiques , Microcirculation/imagerie diagnostique , Microcirculation/effets des médicaments et des substances chimiques , Facteurs de risque , Facteurs tempsRÉSUMÉ
We have recently demonstrated that endothelium-derived hydrogen peroxide (H2O2) is an endothelium-derived hyperpolarizing factor and that endothelial Cu/Zn-superoxide dismutase (SOD) plays an important role in the synthesis of endogenous H2O2 in both animals and humans. We examined whether SOD plays a role in the synthesis of endogenous H2O2 during in vivo reactive hyperemia (RH), an important regulatory mechanism. Mesenteric arterioles from wild-type and Cu,Zn-SOD(-/-) mice were continuously observed by a pencil-type charge-coupled device (CCD) intravital microscope during RH (reperfusion after 20 and 60 s of mesenteric artery occlusion) in the cyclooxygenase blockade under the following four conditions: control, catalase alone, N(G)-monomethyl-L-arginine (L-NMMA) alone, and L-NMMA + catalase. Vasodilatation during RH was significantly decreased by catalase or L-NMMA alone and was almost completely inhibited by L-NMMA + catalase in wild-type mice, whereas it was inhibited by L-NMMA and L-NMMA + catalase in the Cu,Zn-SOD(-/-) mice. RH-induced increase in blood flow after L-NMMA was significantly increased in the wild-type mice, whereas it was significantly reduced in the Cu,Zn-SOD(-/-) mice. In mesenteric arterioles of the Cu,Zn-SOD(-/-) mice, Tempol, an SOD mimetic, significantly increased the ACh-induced vasodilatation, and the enhancing effect of Tempol was decreased by catalase. Vascular H(2)O(2) production by fluorescent microscopy in mesenteric arterioles after RH was significantly increased in response to ACh in wild-type mice but markedly impaired in Cu,Zn-SOD(-/-) mice. Endothelial Cu,Zn-SOD plays an important role in the synthesis of endogenous H(2)O(2) that contributes to RH in mouse mesenteric smaller arterioles.
Sujet(s)
Peroxyde d'hydrogène/métabolisme , Hyperhémie/métabolisme , Mésentère/vascularisation , Circulation splanchnique , Superoxide dismutase/métabolisme , Vasodilatation , Vasodilatateurs/métabolisme , Acétylcholine/pharmacologie , Animaux , Artérioles/métabolisme , Artérioles/physiopathologie , Pression sanguine , Dioxyde de carbone/sang , Catalase/métabolisme , N-oxydes cycliques/pharmacologie , Inhibiteurs des cyclooxygénases/pharmacologie , Relation dose-effet des médicaments , Endothélium vasculaire/métabolisme , Endothélium vasculaire/physiopathologie , Antienzymes/pharmacologie , Rythme cardiaque , Hyperhémie/enzymologie , Hyperhémie/physiopathologie , Indométacine/pharmacologie , Mâle , Souris , Souris knockout , Microscopie de fluorescence , Vidéomicroscopie , Monoxyde d'azote/métabolisme , Nitric oxide synthase/antagonistes et inhibiteurs , Nitric oxide synthase/métabolisme , Oxygène/sang , Marqueurs de spin , Circulation splanchnique/effets des médicaments et des substances chimiques , Superoxide dismutase/déficit , Superoxide dismutase/génétique , Facteurs temps , Vasodilatation/effets des médicaments et des substances chimiques , Vasodilatateurs/pharmacologie , oméga-N-Méthylarginine/pharmacologieRÉSUMÉ
OBJECTIVES: We examined whether endogenous hydrogen peroxide (H2O2) is involved in pacing-induced metabolic vasodilation in vivo. BACKGROUND: We have previously demonstrated that endothelium-derived H2O2 is an endothelium-derived hyperpolarizing factor in canine coronary microcirculation in vivo. However, the role of endogenous H2O2 in metabolic coronary vasodilation in vivo remains to be examined. METHODS: Canine subepicardial small coronary arteries (> or =100 microm) and arterioles (<100 microm) were continuously observed by a microscope under cyclooxygenase blockade (ibuprofen, 12.5 mg/kg intravenous [IV]) (n = 60). Experiments were performed during paired right ventricular pacing under the following 7 conditions: control, nitric oxide (NO) synthase inhibitor (N(G)-monomethyl-L-arginine [L-NMMA], 2 micromol/min for 20 min intracoronary [IC]), catalase (a decomposer of H2O2, 40,000 U/kg IV and 240,000 U/kg/min for 10 min IC), 8-sulfophenyltheophylline (SPT) (an adenosine receptor blocker, 25 mug/kg/min for 5 min IC), L-NMMA+catalase, L-NMMA+tetraethylammonium (TEA) (K(Ca)-channel blocker, 10 microg/kg/min for 10 min IC), and L-NMMA+catalase+8-SPT. RESULTS: Cardiac tachypacing (60 to 120 beats/min) caused coronary vasodilation in both-sized arteries under control conditions in response to the increase in myocardial oxygen consumption. The metabolic coronary vasodilation was decreased after L-NMMA in subepicardial small arteries with an increased fluorescent H2O2 production compared with catalase group, whereas catalase decreased the vasodilation of arterioles with an increased fluorescent NO production compared with the L-NMMA group, and 8-SPT also decreased the vasodilation of arterioles. Furthermore, the metabolic coronary vasodilation was markedly attenuated after L-NMMA+catalase, L-NMMA+TEA, and L-NMMA+catalase+8-SPT in both-sized arteries. CONCLUSIONS: These results indicate that endogenous H2O2 plays an important role in pacing-induced metabolic coronary vasodilation in vivo.
Sujet(s)
Entraînement électrosystolique , Vaisseaux coronaires/anatomopathologie , Peroxyde d'hydrogène/métabolisme , Myocarde/métabolisme , Vasodilatation/effets des médicaments et des substances chimiques , Animaux , Antioxydants/pharmacologie , Catalase/pharmacologie , Circulation coronarienne/effets des médicaments et des substances chimiques , Vaisseaux coronaires/effets des médicaments et des substances chimiques , Vaisseaux coronaires/métabolisme , Inhibiteurs des cyclooxygénases/pharmacologie , Chiens , Antienzymes/pharmacologie , Femelle , Ibuprofène/pharmacologie , Mâle , Microcirculation , Microscopie de fluorescence , Monoxyde d'azote/métabolisme , Consommation d'oxygène , Inhibiteurs des canaux potassiques/pharmacologie , Tétraéthyl-ammonium/pharmacologie , Théophylline/analogues et dérivés , Théophylline/pharmacologie , Vasodilatateurs/pharmacologie , oméga-N-Méthylarginine/pharmacologieRÉSUMÉ
We examined whether edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a free radical scavenger, exerts its protective effect on coronary microvessels after ischemia/reperfusion (I/R) in vivo. Ninety-minute coronary occlusion followed by reperfusion was performed in 16 open-chest dogs with and without edaravone administration. Coronary small artery (> or = 100 microm in size) and arteriolar (< 100 microm) vasodilation, in the presence of endothelium-dependent (acetylcholine) or -independent (papaverine) vasodilators, was directly observed using intravital microscopy before and after I/R. I/R impaired microvascular vasodilation in response to acetylcholine, whereas administration of edaravone preserved the response in microvessels of both sizes, but to a greater extent in the coronary small arteries. No significant changes were noted with papaverine administration. In the edaravone group, the fluorescent intensity from reactive oxygen species (ROS) was lower, whereas nitric oxide (NO) intensity was higher relative to controls in the microvessels of the ischemic area. In conclusion, edaravone preserves coronary microvascular endothelial function after I/R in vivo. These effects, which were NO-mediated, were attributed to the ROS scavenging properties of edaravone.
Sujet(s)
Phénazone/analogues et dérivés , Vaisseaux coronaires/effets des médicaments et des substances chimiques , Piégeurs de radicaux libres/pharmacologie , Lésion de reperfusion myocardique/traitement médicamenteux , Animaux , Phénazone/pharmacologie , Pression sanguine/effets des médicaments et des substances chimiques , Technique de Western , Circulation coronarienne/effets des médicaments et des substances chimiques , Vaisseaux coronaires/physiopathologie , Chiens , Édaravone , Endothélium vasculaire/effets des médicaments et des substances chimiques , Endothélium vasculaire/physiopathologie , Femelle , Rythme cardiaque/effets des médicaments et des substances chimiques , Mâle , Microscopie , Monoxyde d'azote/métabolisme , Espèces réactives de l'oxygène/métabolisme , Vasodilatation/effets des médicaments et des substances chimiquesRÉSUMÉ
We have previously reported that the prolonged transient acidosis during early reperfusion mediates the cardioprotective effects in canine hearts. Recently, postconditioning has been shown to be one of the novel strategies to mediate cardioprotection. We tested the contribution of the prolonged transient acidosis to the cardioprotection of postconditioning. Open-chest anesthetized dogs subjected to 90-min occlusion of the left anterior descending coronary artery and 6-h reperfusion were divided into four groups: 1) control group; no intervention after reperfusion (n = 6); 2) postconditioning (Postcon) group; four cycles of 1-min reperfusion and 1-min reocclusion (n = 7); 3) Postcon + sodium bicarbonate (NaHCO(3)) group; four cycles of 1-min reperfusion and 1-min reocclusion with the administration of NaHCO(3) (n = 8); and 4) NaHCO(3) group; administration of NaHCO(3) without postconditioning (n = 6). Infarct size, the area at risk (AAR), collateral blood flow during ischemia, and pH in coronary venous blood were measured. The phosphorylation of Akt and extracellular signal-regulated kinase (ERK) in ischemic myocardium was assessed by Western blot analysis. Systemic hemodynamic parameters, AAR, and collateral blood flow were not different among the four groups. Postconditioning induced prolonged transient acidosis during the early reperfusion phase. Administration of NaHCO(3) completely abolished the infarct size-limiting effects of postconditioning. Furthermore, the phosphorylation of Akt and ERK in ischemic myocardium induced by postconditioning was also blunted by the cotreatment of NaHCO(3). In conclusion, postconditioning mediates its cardioprotective effects possibly via prolonged transient acidosis during the early reperfusion phase with the activation of Akt and ERK.
Sujet(s)
Acidose/métabolisme , Préconditionnement ischémique myocardique , Lésion de reperfusion myocardique/métabolisme , Lésion de reperfusion myocardique/prévention et contrôle , Animaux , Circulation collatérale/physiologie , Circulation coronarienne/physiologie , Chiens , Extracellular Signal-Regulated MAP Kinases/métabolisme , Concentration en ions d'hydrogène/effets des médicaments et des substances chimiques , Système de signalisation des MAP kinases/effets des médicaments et des substances chimiques , Système de signalisation des MAP kinases/physiologie , Infarctus du myocarde/métabolisme , Infarctus du myocarde/prévention et contrôle , Reperfusion myocardique , Lésion de reperfusion myocardique/mortalité , Phosphatidylinositol 3-kinases/métabolisme , Phosphorylation/effets des médicaments et des substances chimiques , Protéines proto-oncogènes c-akt/métabolisme , Hydrogénocarbonate de sodium/pharmacologie , Veines/physiologieRÉSUMÉ
OBJECTIVES: We investigated the effects of erythropoietin (EPO) on neovascularization and cardiac function after myocardial infarction (MI). BACKGROUND: Erythropoietin exerts antiapoptotic effects and mobilizes endothelial progenitor cells (EPCs). METHODS: We intravenously administered EPO (1,000 IU/kg) immediately [EPO(0) group], 6 h [EPO(6h) group], or 1 week [EPO(1wk) group] after the permanent ligation of the coronary artery in dogs. Control animals received saline immediately after the ligation. RESULTS: The infarct size 6 h after MI was significantly smaller in the EPO(0) group than in the control group (61.5 +/- 6.0% vs. 22.9 +/- 2.2%). One week after MI, the circulating CD34-positive mononuclear cell numbers in both the EPO(0) and the EPO(6h) groups were significantly higher than in the control group. In the ischemic region, the capillary density and myocardial blood flow 4 weeks after MI was significantly higher in both the EPO(0) and the EPO(6h) groups than in the control group. Four weeks after MI, left ventricular (LV) ejection fraction in the EPO(6h) (48.6 +/- 1.9%) group was significantly higher than that in either the control (41.9 +/- 0.9%) or the EPO(1wk) (42.6 +/- 1.2%) group but significantly lower than that in the EPO(0) group (56.1 +/- 2.3%). The LV end-diastolic pressure 4 weeks after MI in both the EPO(0) and the EPO(6h) groups was significantly lower than either the control or the EPO(1wk) group. Hematologic parameters did not differ among the groups. CONCLUSIONS: In addition to its acute infarct size-limiting effect, EPO enhances neovascularization, likely via EPC mobilization, and improves cardiac dysfunction in the chronic phase, although it has time-window limitations.
Sujet(s)
Circulation coronarienne/effets des médicaments et des substances chimiques , Érythropoïétine/usage thérapeutique , Infarctus du myocarde/traitement médicamenteux , Néovascularisation physiologique/effets des médicaments et des substances chimiques , Dysfonction ventriculaire gauche/physiopathologie , Animaux , Antigènes CD34/analyse , Vaisseaux capillaires/anatomie et histologie , Chiens , Hémodynamique , Agranulocytes/immunologie , Infarctus du myocarde/sang , Infarctus du myocarde/anatomopathologie , Infarctus du myocarde/physiopathologie , Facteur de croissance endothéliale vasculaire de type A/sang , Dysfonction ventriculaire gauche/étiologieRÉSUMÉ
PURPOSE: Recent studies suggest that G-CSF prevents cardiac remodeling following myocardial infarction (MI) likely through regeneration of the myocardium and coronary vessels. However, it remains unclear whether G-CSF administered at the onset of reperfusion prevents ischemia/reperfusion injury in the acute phase. We investigated acute effects of G-CSF on myocardial infarct size and the incidence of lethal arrhythmia and evaluated the involvement of the phosphatidylinositol-3 kinase (PI3K) in the in vivo canine models. METHODS: In open-chest dogs, left anterior descending coronary artery (LAD) was occluded for 90 minutes followed by 6 hours of reperfusion. We intravenously administered G-CSF (0.33 micro/kg/min) for 30 minutes from the onset of reperfusion. Wortmannin, a PI3K inhibitor, was selectively administered into the LAD after the onset of reperfusion. RESULTS: G-CSF significantly (p<0.05) reduced myocardial infarct size (38.7+/-4.3% to 15.7+/-5.3%) and the incidence of ventricular fibrillation during reperfusion periods (50% to 0%) compared with the control. G-CSF enhanced Akt phospholylation in ischemic canine myocardium. Wortmannin blunted both the infarct size-limiting and anti-arrhythmic effects of G-CSF. G-CSF did not change myeloperoxidase activity, a marker of neutrophil accumulation, in the infarcted myocardium. CONCLUSION: An intravenous administration of G-CSF at the onset of reperfusion attenuates ischemia/reperfusion injury through PI3K/Akt pathway in the in vivo model. G-CSF administration can be a promising candidate for the adjunctive therapy for patients with acute myocardial infarction.
Sujet(s)
Facteur de stimulation des colonies de granulocytes/usage thérapeutique , Infarctus du myocarde/traitement médicamenteux , Lésion de reperfusion myocardique/prévention et contrôle , Phosphatidylinositol 3-kinases/physiologie , Protéines proto-oncogènes c-akt/physiologie , Animaux , Chiens , Myocarde/métabolisme , Myeloperoxidase/métabolisme , Fibrillation ventriculaire/traitement médicamenteuxRÉSUMÉ
We have recently demonstrated that endogenous H2O2 plays an important role in coronary autoregulation in vivo. However, the role of H2O2 during coronary ischemia-reperfusion (I/R) injury remains to be examined. In this study, we examined whether endogenous H2O2 also plays a protective role in coronary I/R injury in dogs in vivo. Canine subepicardial small coronary arteries (>or=100 microm) and arterioles (<100 microm) were continuously observed by an intravital microscope during coronary I/R (90/60 min) under cyclooxygenase blockade (n=50). Coronary vascular responses to endothelium-dependent vasodilators (ACh) were examined before and after I/R under the following seven conditions: control, nitric oxide (NO) synthase (NOS) inhibitor NG-monomethyl-L-arginine (L-NMMA), catalase (a decomposer of H2O2), 8-sulfophenyltheophylline (8-SPT, an adenosine receptor blocker), L-NMMA+catalase, L-NMMA+tetraethylammonium (TEA, an inhibitor of large-conductance Ca2+-sensitive potassium channels), and L-NMMA+catalase+8-SPT. Coronary I/R significantly impaired the coronary vasodilatation to ACh in both sized arteries (both P<0.01); L-NMMA reduced the small arterial vasodilatation (both P<0.01), whereas it increased (P<0.05) the ACh-induced coronary arteriolar vasodilatation associated with fluorescent H2O2 production after I/R. Catalase increased the small arterial vasodilatation (P<0.01) associated with fluorescent NO production and increased endothelial NOS expression, whereas it decreased the arteriolar response after I/R (P<0.01). L-NMMA+catalase, L-NMMA+TEA, or L-NMMA+catalase+8-SPT further decreased the coronary vasodilatation in both sized arteries (both, P<0.01). L-NMMA+catalase, L-NMMA+TEA, and L-NMMA+catalase+8-SPT significantly increased myocardial infarct area compared with the other four groups (control, L-NMMA, catalase, and 8-SPT; all, P<0.01). These results indicate that endogenous H2O2, in cooperation with NO, plays an important cardioprotective role in coronary I/R injury in vivo.
Sujet(s)
Vaisseaux coronaires/physiopathologie , Peroxyde d'hydrogène/métabolisme , Microcirculation/physiopathologie , Lésion d'ischémie-reperfusion/prévention et contrôle , Lésion d'ischémie-reperfusion/physiopathologie , Acétylcholine/pharmacologie , Adénosine/métabolisme , Animaux , Vaisseaux coronaires/effets des médicaments et des substances chimiques , Chiens , Relation dose-effet des médicaments , Endothélium vasculaire/physiopathologie , Femelle , Hémodynamique/effets des médicaments et des substances chimiques , Hémodynamique/physiologie , Mâle , Microcirculation/effets des médicaments et des substances chimiques , Microcirculation/métabolisme , Infarctus du myocarde/métabolisme , Infarctus du myocarde/anatomopathologie , Infarctus du myocarde/prévention et contrôle , Monoxyde d'azote/métabolisme , Nitric oxide synthase type III/métabolisme , Nitroprussiate/pharmacologie , Lésion d'ischémie-reperfusion/métabolisme , Vasodilatation/effets des médicaments et des substances chimiques , Vasodilatation/physiologie , Vasodilatateurs/pharmacologieRÉSUMÉ
Thyroid hormone (triiodothyronine [T(3)]) has various nongenomic effects, including alterations in glucose and fatty acid metabolism, augmentation of intracellular Ca(2+), enhancement of myocardial contractility, and vascular dilatation. However, its effect on regional blood flow remains to be established. We have measured the effect of T(3) on blood flow in major organs of anesthetized rabbits in vivo using the microsphere method. Under artificial respiration, nonradioactive microspheres (5 x 10(5)) labeled with barium were injected to measure blood flow at control level. Then, T(3) (50 microg/kg per milliliter) was administered and microspheres labeled with iodine (5 x 10(5)) were injected. The atria, ventricles, kidneys, and right upper limb were excised and their contents of microspheres were evaluated. Blood flow in the ventricles was significantly increased by T(3) (2.9 +/- 0.3 versus 3.4 +/- 0.3 mL/min per gram, vehicle versus T(3)). Similarly, blood flow in the kidneys was significantly higher after T(3) injection (4.3 +/- 0.5 versus 5.1 +/- 0.5 mL/min per, vehicle versus T(3)). The blood flow in the atria and skeletal muscles remained unchanged. These results indicate that the vasodilatory response to T(3) is not uniform and occurs preferentially in major organs such as cardiac ventricles and kidneys; this may be relevant to the T(3)-induced improvement of cardiac function.
Sujet(s)
Circulation coronarienne/effets des médicaments et des substances chimiques , Circulation rénale/effets des médicaments et des substances chimiques , Tri-iodothyronine/pharmacologie , Vasodilatateurs/pharmacologie , Fonction ventriculaire , Anesthésie , Animaux , Pression sanguine/effets des médicaments et des substances chimiques , Rythme cardiaque/effets des médicaments et des substances chimiques , Microsphères , Muscles squelettiques/vascularisation , Pentobarbital , Lapins , Débit sanguin régional/effets des médicaments et des substances chimiquesRÉSUMÉ
We have previously reported that histamine H(2) blockers may be cardioprotective in patients with chronic heart failure. Since both endogenous histamine and histamine H(2) receptors are present in heart tissue, we tested the hypothesis that the blockade of histamine H(2) receptors mediates protection against reversible or irreversible ischemia and reperfusion injury. In open-chest dogs, the left anterior descending coronary artery was occluded for 90 minutes, followed by reperfusion for 6 hours. Administration of famotidine and cimetidine from 10 minutes before occlusion until after 1 hour of reperfusion reduced infarct size (17.0 +/- 4.1% and 17.8 +/- 2.9% vs. 36.9 +/- 5.9% of the solvent group, respectively) Famotidine administration only during the reperfusion period for 1 hour also attenuated infarct size (22.5 +/- 3.5%). There were no differences in either area at risk or collateral flow among the groups. In another set of experiments, we decreased coronary perfusion pressure in dogs so that the coronary blood flow decreased to 50% of the non-ischemic level. In such conditions, we observed the increases in histamine release compared with non-ischemic conditions (0.04 +/- 0.03 to 0.28 +/- 0.13 ng/ml, p < 0.05). Famotidine improved anaerobic myocardial metabolism gauged by both lactate extraction ratio and myocardial oxygen consumption. We conclude that the blockade of histamine H(2) receptors mediates improvements in the anaerobic myocardial metabolism, and thus protects against ischemia and reperfusion injury.
Sujet(s)
Antihistaminiques des récepteurs H2/métabolisme , Ischémie myocardique/anatomopathologie , Récepteur histaminergique H2/métabolisme , Lésion d'ischémie-reperfusion/anatomopathologie , Animaux , Chiens , Famotidine/pharmacologie , Défaillance cardiaque/métabolisme , Hémodynamique , Lésion de reperfusion myocardique/anatomopathologie , Myocarde/anatomopathologie , Consommation d'oxygène , Perfusion , Pression , Facteurs tempsRÉSUMÉ
The opening of mitochondrial ATP-sensitive K+ (mitoK(ATP)) channels triggers or mediates the infarct size (IS)-limiting effect of ischemic preconditioning (IP). Because ecto-5'-nucleotidase related to IP is activated by PKC, we tested whether the opening of mitoK(ATP) channels activates PKC and contributes to either activation of ecto-5'-nucleotidase or IS-limiting effect. In dogs, IP procedure decreased IS and activated ecto-5'-nucleotidase, both of which were mimicked by transient exposure to either cromakalim or diazoxide, and these effects were blunted by either GF109203X (a PKC inhibitor) or 5-hydroxydecanoate (a mitoK(ATP) channel blocker), but not by HMR-1098 (a surface sarcolenmal K(ATP) channel blocker). Either cromakalim or diazoxide activated both PKC and ecto-5'-nucleotidase, which was blunted by either GF109203X or 5-hydroxydecanoate, but not by HMR-1098. We concluded that the opening of mitoK(ATP) channels contributes to either activation of ecto-5'-nucleotidase or the infarct size-limiting effect via activation of PKC in canine hearts.
Sujet(s)
Adénosine triphosphate/pharmacologie , Ouverture et fermeture des portes des canaux ioniques/physiologie , Préconditionnement ischémique , Mitochondries du myocarde/effets des médicaments et des substances chimiques , Myocarde/métabolisme , Canaux potassiques/métabolisme , Protéine kinase C/métabolisme , 5'-Nucleotidase/métabolisme , Animaux , Benzamides/administration et posologie , Benzamides/pharmacologie , Acides capriques/administration et posologie , Acides capriques/pharmacologie , Chiens , Activation enzymatique/effets des médicaments et des substances chimiques , Hydroxyacides/administration et posologie , Hydroxyacides/pharmacologie , Indoles/administration et posologie , Indoles/pharmacologie , Ouverture et fermeture des portes des canaux ioniques/effets des médicaments et des substances chimiques , Maléimides/administration et posologie , Maléimides/pharmacologie , Mitochondries du myocarde/métabolisme , Myocarde/anatomopathologieRÉSUMÉ
Although recent studies suggest that erythropoietin (EPO) may reduce multiple features of the myocardial ischemia/reperfusion injury, the cellular mechanisms and the clinical implications of EPO-induced cardioprotection are still unclear. Thus, in this study, we clarified dose-dependent effects of EPO administered just before reperfusion on infarct size and the incidence of ventricular fibrillation and evaluated the involvement of the phosphatidylinositol-3 (PI3) kinase in the in vivo canine model. The canine left anterior descending coronary artery was occluded for 90 min followed by 6 h of reperfusion. A single intravenous administration of EPO just before reperfusion significantly reduced infarct size (high dose (1,000 IU/kg): 7.7 +/- 1.6%, low dose (100 IU/kg): 22.1 +/- 2.4%, control: 40.0 +/- 3.6%) in a dose-dependent manner. Furthermore, the high, but not low, dose of EPO administered as a single injection significantly reduced the incidence of ventricular fibrillation during reperfusion (high dose: 0%, low dose: 40.0%, control: 50.0%). An intracoronary administration of a PI3 kinase inhibitor, wortmannin, blunted the infarct size-limiting and anti-arrhythmic effects of EPO. Low and high doses of EPO equally induced Akt phosphorylation and decreased the equivalent number of TUNEL-positive cells in the ischemic myocardium of dogs. These effects of EPO were abolished by the treatment with wortmannin. In conclusion, EPO administered just before reperfusion reduced infarct size and the incidence of ventricular fibrillation via the PI3 kinase-dependent pathway in canine hearts. EPO administration can be a realistic strategy for the treatment of acute myocardial infarction.